Target intelligence / Profile preview

EFCAB6 antisense RNA 1 (EFCAB6-AS1)

Target
EFCAB6-AS1
Molecular classification
Other (Antisense long non-coding RNA)
01

Overview

EFCAB6 antisense RNA 1 (EFCAB6-AS1), also known as CITF22-123F2.1, is a long non-coding RNA (lncRNA) classified as an antisense transcript. Antisense RNAs, including EFCAB6-AS1, are RNA molecules transcribed from the DNA strand opposite to the sense (protein-coding) gene—which in this case is likely the EFCAB6 gene. These molecules typically regulate gene expression in cis (affecting the neighboring gene locus) or in trans (acting on other loci), often through mechanisms involving chromatin modification, mRNA stability, or transcriptional interference[1]. While the detailed biological roles and disease associations of EFCAB6-AS1 have not been independently characterized in the literature, the general class of antisense RNAs has been implicated in diverse biological processes, especially in the epigenetic regulation of gene expression and in the development or progression of cancer[1]. No approved drugs, mechanisms of action, biomarkers, or safety concerns have been specifically reported for EFCAB6-AS1. Note: Information about EFCAB6-AS1 specifically is extremely limited in public scientific repositories. Most available knowledge pertains to the general class of antisense RNAs and well-studied examples like HOTAIR. Additional details about EFCAB6, the protein-coding sense gene, do not apply directly to its antisense RNA and are not included here[2][3].

Other names
CITF22-123F2.1
02

Biological functions

Regulation of gene expressionEpigenetic regulationPossible roles in cell proliferation and cancer biology (by analogy with similar ncRNAs)
03

Disease associations

Cancer (based on general roles for antisense lncRNAs in oncogenesis and gene silencing; specific disease roles for EFCAB6-AS1 are not well defined)Other (potential, but insufficient information for additional roles)

Beyond the preview

Go deeper on EFCAB6 antisense RNA 1 (EFCAB6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EFCAB6 antisense RNA 1 (EFCAB6-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call